. 2016 May 3;311(1):E56–E68. doi: 10.1152/ajpendo.00490.2015

Table 2.

Plasma analytes

	Sed CR	Run CR	Placebo post-WL	Mifepristone post-WL
NEFA (mM)	0.44 ± 0.04^a	0.32 ± 0.04^a	0.47 ± 0.05^a	0.48 ± 0.04^a
CRP (μg/ml)	303 ± 22.6^ab	242 ± 18.6^a	362 ± 11.3^b	358 ± 18.5^b
Leptin (pg/ml)	455 ± 36.1^a	414 ± 61.5^a	1217 ± 200^b	733 ± 83.1^a
Adiponectin (ng/ml)	727 ± 66.9^a	655 ± 54.5^ab	503 ± 66.6^b	653 ± 59.9^ab

All data are mean ± SE; n = 7–10. Fasting plasma analytes.

CRP, C-reactive protein.

Different letter indicates a significant difference (P < 0.05). All data were analyzed by 1-way ANOVA and Tukey's post hoc test.